is zepbound a glp-1 drug FDA approval for (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and hormone receptors - Eli Lilly Weight-Loss Drug Zepbound Now in
Description
(N Y) 2 (11), 12031230
Optimize your weight loss with our GLP-1 Diet, a 4-week program designed around the benefits of GLP-1 receptor agonists
Additional support For details about your medication and dosing, please log in to your patient portal
The weight loss was a fortuitous side effect because semaglutide was originally designed to be a treatment for diabetes
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222
For this reason, they are referred to as prandial GLP-1 receptor agonists
